Presentation ESC 2014 Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry Presenter: Eric Van Belle September 02, 2014
News Conference News ESC 2014 GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular Caitlin E. Cox September 02, 2014
News Conference News ESC 2014 FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients Yael L. Maxwell September 02, 2014
News Conference News ESC 2014 Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis Caitlin E. Cox August 31, 2014
News Conference News ESC 2014 Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device Todd Neale August 31, 2014
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ESC 2013 PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk Yael L. Maxwell September 04, 2013
News Conference News ESC 2013 FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk Caitlin E. Cox September 02, 2013
News Conference News ESC 2012 ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations Caitlin E. Cox September 04, 2012
News Conference News ESC 2012 French, European Registries Add International Flavor to TAVR Assessment August 29, 2012
News Conference News ESC 2012 TAVR Improves Quality of Life, Reduces Hospitalization in German Registry Yael L. Maxwell August 28, 2012
News Conference News ESC 2012 Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research Caitlin E. Cox August 28, 2012
News Conference News ESC 2012 Registries Show Strides for Transcatheter Valve Treatments in Europe Caitlin E. Cox August 27, 2012
News Conference News ESC 2012 Predictors of Aortic Regurgitation After TAVR Delineated August 26, 2012
News Conference News ESC 2012 ESC Congress 2012 Offers Slate of Guidelines, New MI Definition Caitlin E. Cox August 26, 2012